The
following table sets forth the computation of basic and diluted earnings per share:
SCHEDULE OF BASIC AND DILUTED EARNINGS PER SHARE
| | |
2026 | | |
2025 | |
| | |
Three Months Ended | |
| | |
March 31, | |
| | |
2026 | | |
2025 | |
| Numerator for basic and diluted earnings per share: | |
| | | |
| | |
| Net income (Loss) Attributable to Selectis Health, Inc. | |
$ | 6,526,382 | | |
$ | (655,969 | ) |
| Series D Preferred Dividends | |
| (7,500 | ) | |
| (15,000 | ) |
| Net income (loss) attributable to common stockholders – Basic and Diluted | |
$ | 6,518,882 | | |
$ | (670,969 | ) |
| | |
| | | |
| | |
| Denominator for basic and diluted earnings per share: | |
| | | |
| | |
| Weighted average common shares outstanding – Basic | |
| 3,067,059 | | |
| 3,067,059 | |
| Weighted average common shares outstanding – Diluted | |
| 3,442,773 | | |
| 3,067,059 | |
| | |
| | | |
| | |
| Net income (loss) per share attributable to common stockholders: | |
| | | |
| | |
| Basic | |
$ | 2.13 | | |
$ | (0.22 | ) |
| Diluted | |
$ | 1.90 | | |
$ | (0.22 | ) |
|